Vadodara, July 15: The Board of Directors of Gujarat Inject Limited approved the standalone un-audited financial results for the first quarter ended June 30, 2026. The Company has delivered a strong performance, highlighting its robust transition into the high-growth solar and clean energy sector.
FINANCIAL PERFORMANCE HIGHLIGHTS
-
Q1 FY27 Revenue from Operations stood at Rs. 12.45 Crore , representing a spectacular YoY growth of 414.4% compared to Rs. 2.42 Crore in Q1 FY26.
-
Q1 FY27 Standalone Net Profit rose to Rs. 1.25 Crore, a massive expansion from Rs. 0.07 Crore in the corresponding quarter of the previous fiscal year.
-
Comparison with Q4 FY26: Resilient Profitability: While sequential revenue moderated to Rs. 12.45 Crore from the exceptional, peak order-delivery quarter of Q4 FY26 , the company’s bottom-line performance remains remarkably strong. The Standalone PAT of Rs. 1.25 Crore achieved in just the first quarter of FY27 represents a massive 69% of the total Standalone PAT recorded for the entire full year of FY26 . This underscores the significantly higher operational efficiency and profitability margins the business is commanding in its new strategic direction.
-
Earnings Per Share : Stood at Rs. 0.86 per share for Q1 FY27, up substantially from Rs. 0.05 in Q1 FY26.
Standalone Financial Summary Table
|
Particulars (Rs. in Lakhs) |
Q1 FY27 (Unaudited) |
Q4 FY26 (Audited) |
Q1 FY26 (Unaudited) |
FY26 Full Year (Audited) |
|
Revenue from Operations |
1,245.45 |
3,069.77 |
242.12 |
3,632.04 |
|
Other Income |
– |
– |
– |
19.63 |
|
Total Income |
1,245.45 |
3,069.77 |
242.12 |
3,651.67 |
|
Total Expenses |
1,076.69 |
2,843.26 |
232.30 |
3,401.26 |
|
Profit Before Tax (PBT) |
168.76 |
226.51 |
9.82 |
250.41 |
|
Tax Expense |
43.60 |
63.00 |
2.47 |
69.00 |
|
Profit After Tax (PAT) |
125.16 |
163.51 |
7.35 |
181.41 |
|
Basic & Diluted EPS (Rs.) |
0.86 |
1.12 |
0.05 |
1.24 |
LEADERSHIP APPOINTMENT: MR. MURLI SHIVSHANKARAN NAIR APPOINTED AS MANAGING DIRECTOR
In a significant move to strengthen its executive leadership team, the Board of Directors, at its meeting held on 06th July, 2026, approved the appointment of Mr. Murli Shivshankaran Nair as an Additional Director, designated as the Managing Director of the company. His appointment is effective from July 6, 2026, for a tenure of 3 years, subject to the approval of the members of the company at the ensuing general meeting.
Mr. Nair is a seasoned professional with a diverse generalist background and extensive expertise in manufacturing, administration, and corporate development. He possesses a deep understanding of the manufacturing sector and customer dynamics, making him uniquely qualified to lead the company’s ambitious growth roadmap and operational scaling in the clean tech sector.
STRATEGIC BRAND TRANSITION & PROPOSED NAME CHANGE
To align the company’s identity with its strategic business focus, the Board on 14th July, 2026 approved the proposal to change the company’s name from “Gujarat Inject Limited” to “REGENOVA RENEWTECH LIMITED”, subject to shareholder approvals. This rebranding encapsulates the company’s active diversification into the renewable energy segment, specifically its growing footprint in Solar PV module distribution and clean energy solutions.
The transition is supported by the company’s active efforts in executing major solar infrastructure orders and operating its own 5MW solar project in Jakasana, Mehsana . Consequent to the name change, Clause I of the Memorandum of Association and corresponding Articles of Association will be altered to reflect the new name.
Commenting on the progress, Mr. Murli Shivshankaran Nair, Managing Director, said:
“We are entering an incredibly exciting phase at Gujarat Inject. The robust financial results for Q1 FY27 reflect the inherent strength of our new strategic direction. Moving towards a unified brand under REGENOVA RENEWTECH LIMITED signals our commitment to clean energy, sustainability, and long-term value creation. Our focus remains on stellar execution, maintaining strong customer relationships, and scaling our operational platform safely and efficiently.”